ARPO insider filings
Aerpio Pharmaceuticals, Inc. — 16 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-07-02. Screen ARPO transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ARPO between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Aerpio Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2021-07-02 | 4 | Dugel Pravin — Director | Grant/award (A): 6,331 @ $1.52 | EDGAR |
| 2021-07-02 | 4 | Cohen Cheryl — Director | Grant/award (A): 8,140 @ $1.52 | EDGAR |
| 2021-07-02 | 4 | Dalal Anupam — Director | Grant/award (A): 7,400 @ $1.52 | EDGAR |
| 2021-07-02 | 4 | Castelein Caley — Director | Grant/award (A): 7,811 @ $1.52 | EDGAR |
| 2021-07-02 | 4 | Prelack Steven — Director | Grant/award (A): 12,334 @ $1.52 | EDGAR |
| 2021-06-22 | 4 | Cohen Cheryl — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-04-02 | 4 | Cohen Cheryl — Director | Grant/award (A): 8,020 @ $1.54 | EDGAR |
| 2021-04-02 | 4 | Dalal Anupam — Director | Grant/award (A): 7,290 @ $1.54 | EDGAR |
| 2021-04-02 | 4 | Dugel Pravin — Director | Grant/award (A): 6,237 @ $1.54 | EDGAR |
| 2021-04-02 | 4 | Castelein Caley — Director | Grant/award (A): 7,696 @ $1.54 | EDGAR |
| 2021-04-02 | 4 | Prelack Steven — Director | Grant/award (A): 12,151 @ $1.54 | EDGAR |
| 2021-02-03 | 4 | Dugel Pravin — Director | Grant/award (A): 17,857 (derivative) @ $0 | EDGAR |
| 2021-02-03 | 4 | Cohen Cheryl — Director | Grant/award (A): 17,857 (derivative) @ $0 | EDGAR |
| 2021-02-03 | 4 | Dalal Anupam — Director | Grant/award (A): 17,857 (derivative) @ $0 | EDGAR |
| 2021-02-03 | 4 | Castelein Caley — Director | Grant/award (A): 17,857 (derivative) @ $0 | EDGAR |
| 2020-12-10 | 4 | ORBIMED ADVISORS LLC — 10% owner OrbiMed Capital GP V LLC — 10% owner | Option exercise/expiry (X): 21,400 @ $0.96 · Sale (S): 21,400 @ $1.96 · Option exercise/expiry (X): 21,400 (derivative) @ $0 | EDGAR |
Recent 8-K events — Aerpio Pharmaceuticals, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ARPO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs